APA (7th ed.) Citation

A, S., B, B., SR, R., AJM, M., MM, v. d. H., W, X., . . . BC, C. (2023). Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. Therapeutic drug monitoring, 45(3), 345. https://doi.org/10.1097/FTD.0000000000001085

Chicago Style (17th ed.) Citation

A, Siemens, Brooks B, Rassekh SR, Meijer AJM, van den Heuvel-Eibrink MM, Xu W, Loucks CM, Ross CJD, and Carleton BC. "Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children." Therapeutic Drug Monitoring 45, no. 3 (2023): 345. https://doi.org/10.1097/FTD.0000000000001085.

MLA (9th ed.) Citation

A, Siemens, et al. "Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children." Therapeutic Drug Monitoring, vol. 45, no. 3, 2023, p. 345, https://doi.org/10.1097/FTD.0000000000001085.